CRF Health, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, announced the introduction of TrialMax ConMed™.
CRF Health, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, announced the introduction of TrialMax ConMed™, an eDiary-based solution designed to enhance the real-time collection of concomitant medication data from patients in clinical trials.
TrialMax ConMed allows patients to select from a predefined list of commonly taken medications or enter a new drug into their TrialMax Touch® eDiary electronically. With access to TrialManager®, CRF Health’s online patient management portal, investigators are alerted to new medication entries to allow them to assess the completeness and accuracy of the data and correct as appropriate.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.